微质的枯竭减少了人类神经元APOE4相关的病态在阿尔茨海默氏病的模拟模型中
Antara Rao1, Nuo Chen2, Min Joo Kim3
1Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA; Developmental and Stem Cell Biology Graduate Program, University of California, San Francisco, San Francisco, CA, USA.
Cell stem cell
|November 5, 2024
概括
微质和阿波利波蛋白E4 (APOE4) 显著影响阿尔茨海默氏症 (AD) 病理学. 这项研究表明,当神经元表达APOE4时,微质细胞会加剧AD,突出显示它们在疾病进展中的联合作用.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- 阿波利波蛋白E4 (APOE4) 和微质是阿尔茨海默病 (AD) 的关键参与者.
- 微质对APOE4驱动的AD病原体的特定影响尚未完全理解.
- 了解这些相互作用对于开发针对性的AD疗法至关重要.
研究的目的:
- 研究微质在神经元APOE4相关的AD病变发生中的作用.
- 为了确定微质枯竭如何影响粉样β (Aβ) 和tau病理在不同APOE异型的存在.
主要方法:
- 通过将人类诱导多能干细胞 (iPSC) 衍生的神经元 (表达APOE4,APOE3或没有APOE) 移植到小鼠海马中,创建了化学性小鼠模型.
- 在这些嵌合体小鼠的一个子集中,微质细胞被耗尽了.
- 单细胞RNA测序用于分析微质子类型和基因表达.
主要成果:
- 神经间的apolipoprotein E (APOE) 和微质细胞的存在对于Aβ和tau病理的发展至关重要.
- 与APOE3.3相比,APOE4显著加剧了病理.
- 在接受APOE4神经元移植的小鼠中,发现了两种具有增加MHC-II表达的亲炎性微质亚型.
结论:
- 神经细胞APOE,特别是APOE4,和微质细胞协同起作用,驱动AD的病变发生.
- 微质细胞在放大与APOE4相关的AD病理学方面发挥着关键作用.
- 这些发现强调了向AD的APOE4载体中微质激活的治疗潜力.
相关概念视频
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...